微小RNA与癌基因：社交网络的力量 - Suppr

Suppr

超能文献

miRNAs versus oncogenes: the power of social networking.

作者信息

Malumbres Marcos

机构信息

Cell Division and Cancer group, Spanish National Cancer Research Centre, Madrid, Spain.

出版信息

Mol Syst Biol. 2012 Feb 14;8:569. doi: 10.1038/msb.2012.2.

DOI:10.1038/msb.2012.2

PMID:22333973

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3293632/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b6b/3293632/1f910290aaf7/msb20122-f1.jpg

相似文献

miRNAs versus oncogenes: the power of social networking.

Mol Syst Biol. 2012 Feb 14;8:569. doi: 10.1038/msb.2012.2.

Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.

Mol Syst Biol. 2012 Feb 14;8:570. doi: 10.1038/msb.2011.100.

A working model for the time sequence of genetic changes in breast tumorigenesis.

J Am Coll Surg. 2002 Feb;194(2):202-16. doi: 10.1016/s1072-7515(01)01108-5.

MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.

Int J Mol Med. 2016 Jun;37(6):1643-51. doi: 10.3892/ijmm.2016.2557. Epub 2016 Apr 11.

The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.

Aging (Albany NY). 2021 Apr 26;13(10):13663-13679. doi: 10.18632/aging.202909.

MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network.

J Biol Chem. 2012 Dec 14;287(51):42695-707. doi: 10.1074/jbc.M112.387761. Epub 2012 Oct 26.

Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.

J Pathol. 2016 Aug;239(4):459-72. doi: 10.1002/path.4743. Epub 2016 Jul 1.

Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.

Funct Integr Genomics. 2019 Jul;19(4):645-658. doi: 10.1007/s10142-019-00670-7. Epub 2019 Mar 12.

Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.

Biomed Pharmacother. 2013 Sep;67(7):629-36. doi: 10.1016/j.biopha.2013.06.006. Epub 2013 Jul 12.

MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.

Tumour Biol. 2016 Nov;37(11):15325-15332. doi: 10.1007/s13277-016-5444-9. Epub 2016 Oct 4.

引用本文的文献

Cholesterol-Conjugated Polyion Complex Nanoparticles for Combination Delivery of Hydrophobic Paclitaxel and Hydrophilic miR-34a for Colon Cancer Therapy.

Int J Mol Sci. 2025 Aug 18;26(16):7965. doi: 10.3390/ijms26167965.

miRNA-6236 Regulation of Postischemic Skeletal Muscle Angiogenesis.

J Am Heart Assoc. 2024 Dec 3;13(23):e035923. doi: 10.1161/JAHA.124.035923. Epub 2024 Nov 27.

Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.

Mol Biol Rep. 2022 Jul;49(7):5973-5984. doi: 10.1007/s11033-022-07381-6. Epub 2022 Mar 30.

Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.

Clin Transl Oncol. 2020 Jan;22(1):60-69. doi: 10.1007/s12094-019-02131-w. Epub 2019 May 15.

Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma.

Mol Med Rep. 2017 Jun;15(6):4109-4115. doi: 10.3892/mmr.2017.6490. Epub 2017 Apr 20.

Assessing Low-Intensity Relationships in Complex Networks.

PLoS One. 2016 Apr 20;11(4):e0152536. doi: 10.1371/journal.pone.0152536. eCollection 2016.

Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.

Oncogenesis. 2016 Feb 15;5(2):e194. doi: 10.1038/oncsis.2016.4.

MicroRNA, Pm-miR-2305, Participates in Nacre Formation by Targeting Pearlin in Pearl Oyster Pinctada martensii.

Int J Mol Sci. 2015 Sep 7;16(9):21442-53. doi: 10.3390/ijms160921442.

miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development.

Biomed Res Int. 2015;2015:304584. doi: 10.1155/2015/304584. Epub 2015 Jun 9.

Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer.

Sci Rep. 2015 Jan 27;5:8013. doi: 10.1038/srep08013.

本文引用的文献

Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.

Mol Syst Biol. 2012 Feb 14;8:570. doi: 10.1038/msb.2011.100.

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.

Nat Med. 2011 Dec 11;18(1):74-82. doi: 10.1038/nm.2577.

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.

Blood. 2011 Jun 9;117(23):6255-66. doi: 10.1182/blood-2010-10-315432. Epub 2011 Apr 8.

MicroRNAs and the cell cycle.

Biochim Biophys Acta. 2011 May;1812(5):592-601. doi: 10.1016/j.bbadis.2011.02.002. Epub 2011 Feb 18.

Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway.

Curr Cancer Drug Targets. 2010 Dec;10(8):824-33. doi: 10.2174/156800910793357961.

Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Nat Rev Clin Oncol. 2010 Sep;7(9):493-507. doi: 10.1038/nrclinonc.2010.97. Epub 2010 Jun 15.

EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Sci Signal. 2010 Jun 1;3(124):ra43. doi: 10.1126/scisignal.2000876.

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region.

Oncogene. 2010 Apr 15;29(15):2302-8. doi: 10.1038/onc.2010.34. Epub 2010 Mar 1.

Role of miR-143 targeting KRAS in colorectal tumorigenesis.

Oncogene. 2009 Mar 12;28(10):1385-92. doi: 10.1038/onc.2008.474. Epub 2009 Jan 12.

Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.

J Biol Chem. 2009 Feb 27;284(9):5731-41. doi: 10.1074/jbc.M804280200. Epub 2008 Dec 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验